Work

Kanglexin counters vascular smooth muscle cell dedifferentiation and associated arteriosclerosis through inhibiting PDGFR

Year: 2024

Type: article

Source: Phytomedicine

DOI: 10.1016/j.phymed.2024.155704

Authors: Shuang Yang, Yixiu Zhao, Shifeng Cao, Xinxin Liu, Min Feng, Yi Chen, Chunyue Ma, Tingting Zhan, Qi Zhang, Honglin Jia, Yu Zhao, Ming Tong, Yuanyuan Yu, Xue Liu, Baofeng Yang, Yan Zhang

Institutions: Harbin Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College

Language: English

Topic: Atherosclerosis and Cardiovascular Diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences, Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Awards: G2066077574, G4402661917, G4445583553, G5994215764, G8894868219

OpenAlex ID: W4396544941

FWCI: 1.544

Cites: 59

Cited by: 10

Related to: 10